MedTrace Logo

Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

NCT02589405 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-02-18

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Benzoyl Peroxide

OTHER

Dermotivin® Soft Liquid cleanser

OTHER

Cetaphil® Dermacontrol Moisturizer SPF30

Sponsors & Collaborators

  • Proinnovera GmbH

    collaborator INDUSTRY

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Mi-Ran EGBERT, MD · Proinnovera GmbH

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02589405 on ClinicalTrials.gov